期刊文献+

VEGF和TNF-a在子宫内膜异位症患者血清和腹腔液中的表达及意义 被引量:2

Expression and significance of VEGF and TNF-a in patients with endometriosis and peritoneal fluid
原文传递
导出
摘要 目的探讨血管内皮生长因子(VEGF)和肿瘤坏死因子(TNF—α)在子宫内膜异位症(EMS)患者血清和腹腔液中的表达及其对临床的指导意义。方法采用双抗体夹心ELISA法检测子宫内膜异位症患者血清中VEGF和TNF—α水平,并进行相关性分析。结果EMS组患者血清和腹腔液中TNF—α和VEGF水平较对照组高,差异有显著性(P〈0.05)。两组患者血清和腹腔液中TNF—α水平和VEGF水平在Ⅲ。Ⅳ期均明显高于I~Ⅱ期,差异有显著性(P〈0.05)。结论EMS患者血清和腹腔液中TNF—α和VEGF水平明显升高,且随疾病的发展而逐步升高,说明VEGF和TNF—α在EMS的发生发展中起重要作用,并有望成为EMS的辅助性诊断指标。 Objective To investigate the expression of vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF -α) in the endometriosis (EMS) in serum and peritoneal fluid and its effect on clinical significance. Methods The double - antibody sandwich ELISA endometriosis was detected in serum levels of VEGF and TNF - α, and do a correlation analysis. Results EMS patients in peritoneal fluid and serum levels of TNF - α and VEGF was higher than those of the control group, there is statistically significant difference ( P 〈 0. 05). Two groups of patients in the peritoneal fluid and serum TNF - α levels and VEGF levels in stage Ⅲ - Ⅳwere significantly higher than those the I - Ⅱ period, the difference was statistically significant ( P 〈 0.05 ). Conclusions EMS in perho- Meal fluid and serum TNF - α and VEGF levels were significantly increased, and with the development of the disease increased gradually, indicating that VEGF and TNF - α in the development of EMS, play an important role, and is expected to be EMS, auxiliary diagnostic index.
作者 林芳惠
出处 《医药论坛杂志》 2011年第15期27-28,31,共3页 Journal of Medical Forum
关键词 子宫内膜异位症 血管内皮生长因子(VEGF) 表达 Endometriosis Vascular endothelial growth factor (VEGF) Expression
  • 相关文献

参考文献7

二级参考文献43

  • 1刘瑾,张磊,赵晓岚,晋芳,蔡小宁,刘琦.子宫内膜异位症患者血清EMAb、ASAb检测的临床意义[J].陕西医学杂志,2004,33(11):985-986. 被引量:1
  • 2于静,王化丽,王长智.Bcl-2蛋白在子宫内膜异位症的表达及意义[J].中国妇幼保健,2004,19(3):34-36. 被引量:6
  • 3郑怀美.妇产科学(第3版)[M].北京:北京人民出版社,1993.206.
  • 4Sattler M, Liang H, Nettesheim D, et al. Structure of bcl-x and bak peptide complex recognition between regulators of apoptosis. Science, 1997,275 : 983-986.
  • 5Freitas S, Meduri G, Le-Nestour E. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod, 1999, 61 (4) : 1070- 1082.
  • 6Krajewski S, Krajewska M, Shabaik A, et al. Immunohisto chemical Determination of in vivo distribution of bax dominant inhibitor of bcl-2. Am J Pathol, 1994,144:1195-1120.
  • 7Mclaren J. Vascular endothelial growth factors and endometriotic angiogenesis. Hum Reprod Update, 2000, 6:45-52.
  • 8Rosenstein JM, Mani N, Silverman WF. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci U S A, 1998, 95: 7086-7091.
  • 9Lyall F, Young A, Boswell F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placental, 1997, 18: 269-276.
  • 10Zagzag D. Angiogenic growth factor in neural embryogenesis and meoplasia. Am J Pathol, 1995, 146: 293-299.

共引文献35

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部